Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
SABS
SABS News & Events
-
Add to Watchlist
Trade SABS Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
SABS News
SAB Biotherapeutics Reports Q1 Financial Results with Significant Loss
May 12 2026
seekingalpha
SAB Biotherapeutics Advances SAFEGUARD Trial Enrollment
May 12 2026
Newsfilter
Rare Hantavirus Outbreak Sparks Market Response
May 11 2026
stocktwits
Emergent BioSolutions Signs $50 Million Agreement with SAB Biotherapeutics
Apr 29 2026
Globenewswire
Emergent BioSolutions Signs $50 Million Agreement with SAB Biotherapeutics
Apr 29 2026
Newsfilter
SAB Bio Reveals New Clinical and Mechanistic Findings from SAB-142 Phase 1 Trial in Adults with Established Autoimmune Type 1 Diabetes at IDS 2026
Apr 22 2026
moomoo
SAB Biotherapeutics Completes $85M Stock Offering
Mar 18 2026
seekingalpha
SAB Biotherapeutics Launches Public Offering to Fund Diabetes Candidate
Mar 17 2026
seekingalpha
Show More News
SABS Events
No data
SABS Monitor News
No data
SABS Earnings Analysis
No Data
People Also Watch
